List of works - Courtney Hudgens

A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors

scientific article published on 15 April 2019

A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma

scientific article published on 22 August 2019

A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1.

scientific article published on 20 September 2016

Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

scientific article published on 01 December 2018

B cells and tertiary lymphoid structures promote immunotherapy response

scientific article published on 15 January 2020

Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial

scientific article published on 28 April 2016

Erratum to: A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1.

scientific article published on 18 January 2017

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.

scientific article

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

scientific article published on 2 November 2017

High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma

scientific article published on 26 July 2018

Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes

scientific article

Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade.

scientific article published on 6 January 2017

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

scientific article published on 8 October 2018

Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer

scientific article published on 01 May 2019

Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma